MGI Cements Its Presence and Contribution in Singapore's Genomics Landscape at ESMO Asia Congress 2022
SINGAPORE, Dec. 1, 2022 /PRNewswire/ --MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, will join global and Asian cancer professionals at the ESMO Asia Congress 2022 taking place 2-4 December in Singapore. In addition, MGI will introduce a free trial campaign on its latest sequencer DNBSEQ-G99* for early users in APAC at the event(more details can be found here). At ESMO, MGI sets to showcase its MGISP-100 Automated Sample Preparation System and DNBSEQ-G99* Genetic Sequencer at Booth C209. Suitable for small and medium-sized research lab...
Source: philippinetimes.com